Connection

Search Results to Elaine M. Hylek, MD

This is a "connection" page, showing the details of why an item matched the keywords from your search.

                     
                     

One or more keywords matched the following properties of Hylek, Elaine

PropertyValue
Research Expertise & Professional Interests Expertise includes: Arterial Thrombosis; Venous Thrombosis; Atrial Fibrillation; Safety and Effectiveness of Antithrombotic Therapy.
Self-Described Keywords Antithrombotic Therapy

One or more keywords matched the following items that are connected to Hylek, Elaine

Item TypeName
Concept Drug Therapy, Combination
Concept Therapeutic Equivalency
Concept Thrombolytic Therapy
Concept Treatment Outcome
Concept Withholding Treatment
Concept Medication Therapy Management
Concept Cardiac Resynchronization Therapy
Concept Cardiac Resynchronization Therapy Devices
Academic Article Prospective study of the outcomes of ambulatory patients with excessive warfarin anticoagulation.
Academic Article Clinical predictors of prolonged delay in return of the international normalized ratio to within the therapeutic range after excessive anticoagulation with warfarin.
Academic Article Anticoagulation therapy for stroke prevention in atrial fibrillation: how well do randomized trials translate into clinical practice?
Academic Article Complications of oral anticoagulant therapy: bleeding and nonbleeding, rates and risk factors.
Academic Article The pharmacology and management of the vitamin K antagonists: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy.
Academic Article Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation.
Academic Article Warfarin maintenance dosing patterns in clinical practice: implications for safer anticoagulation in the elderly population.
Academic Article Antithrombotic therapy in atrial fibrillation.
Academic Article Does preadmission anticoagulation therapy reduce stroke severity in patients with atrial fibrillation?
Academic Article A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.
Academic Article A risk model predicted major bleeding in older patients with atrial fibrillation receiving warfarin therapy.
Academic Article Major hemorrhage and tolerability of warfarin in the first year of therapy among elderly patients with atrial fibrillation.
Academic Article DU-176b, an oral, direct Factor Xa antagonist.
Academic Article Methodological considerations for interpretation of rates of major haemorrhage in studies of anticoagulant therapy for atrial fibrillation.
Academic Article Risk of thromboembolism with short-term interruption of warfarin therapy.
Academic Article Effectiveness of warfarin among patients with cancer.
Academic Article Contra: 'Warfarin should be the drug of choice for thromboprophylaxis in elderly patients with atrial fibrillation'. Caveats regarding use of oral anticoagulant therapy among elderly patients with atrial fibrillation.
Academic Article Thromboembolic consequences of subtherapeutic anticoagulation in patients stabilized on warfarin therapy: the low INR study.
Academic Article Warfarin for atrial fibrillation in community-based practise.
Academic Article Delivery of optimized anticoagulant therapy: consensus statement from the Anticoagulation Forum.
Academic Article Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Academic Article Antithrombotic therapy in atrial fibrillation: guidelines translated for the clinician.
Academic Article Oral anticoagulant therapy for patients with atrial fibrillation--an update.
Academic Article Dual antiplatelet and oral anticoagulant therapy: increasing use and precautions for a hazardous combination.
Academic Article Antithrombotic prophylaxis in elderly patients with atrial fibrillation.
Academic Article Apixaban for reduction in stroke and other ThromboemboLic events in atrial fibrillation (ARISTOTLE) trial: design and rationale.
Academic Article Outcomes and predictors of very stable INR control during chronic anticoagulation therapy.
Academic Article Incidence and predictors of bleeding or thrombosis after polypectomy in patients receiving and not receiving anticoagulation therapy.
Academic Article High blood pressure while taking antithrombotic medication is associated with an increased risk of developing intracranial haemorrhage.
Academic Article New-onset atrial fibrillation and warfarin initiation: high risk periods and implications for new antithrombotic drugs.
Academic Article Risk-adjusted percent time in therapeutic range as a quality indicator for outpatient oral anticoagulation: results of the Veterans Affairs Study to Improve Anticoagulation (VARIA).
Academic Article Therapeutic potential of oral factor Xa inhibitors.
Academic Article Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options--a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference.
Academic Article Apixaban versus warfarin in patients with atrial fibrillation.
Academic Article Outcomes registry for better informed treatment of atrial fibrillation: rationale and design of ORBIT-AF.
Academic Article Brand name versus generic warfarin: a systematic review of the literature.
Academic Article Comprehensive risk reduction in patients with atrial fibrillation: Emerging diagnostic and therapeutic options. Executive summary of the report from the 3rd AFNET/EHRA consensus conference.
Academic Article Oral anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Academic Article Antithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.
Academic Article Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for gastrointestinal tract bleeding.
Academic Article Efficacy and safety of apixaban compared with warfarin according to patient risk of stroke and of bleeding in atrial fibrillation: a secondary analysis of a randomised controlled trial.
Academic Article Identifying major hemorrhage with automated data: results of the Veterans Affairs study to improve anticoagulation (VARIA).
Academic Article Vitamin K antagonists and time in the therapeutic range: implications, challenges, and strategies for improvement.
Academic Article Risks and benefits of anticoagulation in atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article Comparison of ischemic stroke outcomes and patient and hospital characteristics by race/ethnicity and socioeconomic status.
Academic Article Anticoagulation therapy for atrial fibrillation.
Academic Article Efficacy and safety of apixaban compared with warfarin at different levels of predicted international normalized ratio control for stroke prevention in atrial fibrillation.
Academic Article Nonadherence with INR monitoring and anticoagulant complications.
Academic Article Use and associated risks of concomitant aspirin therapy with oral anticoagulation in patients with atrial fibrillation: insights from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Registry.
Academic Article Apixaban versus warfarin in patients with atrial fibrillation according to prior warfarin use: results from the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation trial.
Academic Article Early adoption of dabigatran and its dosing in US patients with atrial fibrillation: results from the outcomes registry for better informed treatment of atrial fibrillation.
Academic Article Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article Amiodarone, anticoagulation, and clinical events in patients with atrial fibrillation: insights from the ARISTOTLE trial.
Academic Article Management and clinical outcomes in patients treated with apixaban vs warfarin undergoing procedures.
Academic Article Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Academic Article Antiplatelet therapy in prevention of cardio- and venous thromboembolic events.
Academic Article High-sensitivity troponin I for risk assessment in patients with atrial fibrillation: insights from the Apixaban for Reduction in Stroke and other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) trial.
Academic Article Efficacy and safety of apixaban compared with warfarin according to age for stroke prevention in atrial fibrillation: observations from the ARISTOTLE trial.
Academic Article D-dimer and risk of thromboembolic and bleeding events in patients with atrial fibrillation--observations from the ARISTOTLE trial.
Academic Article Predicting outcomes among patients with atrial fibrillation and heart failure receiving anticoagulation with warfarin.
Academic Article National assessment of warfarin anticoagulation therapy for stroke prevention in atrial fibrillation.
Academic Article Comparing patient-level and site-level anticoagulation control as predictors of adverse events.
Academic Article Outcomes of anticoagulation therapy in patients with mental health conditions.
Academic Article Stratifying the risks of oral anticoagulation in patients with liver disease.
Academic Article Addressing barriers to optimal oral anticoagulation use and persistence among patients with atrial fibrillation: Proceedings, Washington, DC, December 3-4, 2012.
Academic Article Clinical outcomes and management associated with major bleeding in patients with atrial fibrillation treated with apixaban or warfarin: insights from the ARISTOTLE trial.
Academic Article Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis.
Academic Article High-sensitivity troponin T and risk stratification in patients with atrial fibrillation during treatment with apixaban or warfarin.
Academic Article Drivers of hospitalization for patients with atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Academic Article Cardiac tachyarrhythmias and patient values and preferences for their management: the European Heart Rhythm Association (EHRA) consensus document endorsed by the Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE).
Academic Article Digoxin Use and Subsequent Outcomes Among Patients in a Contemporary Atrial Fibrillation Cohort.
Academic Article Risk of thromboembolism, recurrent hemorrhage, and death after warfarin therapy interruption for intracranial hemorrhage.
Academic Article Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II: rationale and design of the ORBIT-AF II registry.
Academic Article Patients'' time in therapeutic range on warfarin among US patients with atrial fibrillation: Results from ORBIT-AF registry.
Academic Article Lack of concordance between empirical scores and physician assessments of stroke and bleeding risk in atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article Design and rationale for RE-VERSE AD: A phase 3 study of idarucizumab, a specific reversal agent for dabigatran.
Academic Article Association Between Atrial Fibrillation Symptoms, Quality of Life, and Patient Outcomes: Results From the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF).
Academic Article Differences in Clinical and Functional Outcomes of Atrial Fibrillation in Women and Men: Two-Year Results From the ORBIT-AF Registry.
Academic Article Blood Pressure Control and Risk of Stroke or Systemic Embolism in Patients With Atrial Fibrillation: Results From the Apixaban for Reduction in Stroke and Other Thromboembolic Events in Atrial Fibrillation (ARISTOTLE) Trial.
Academic Article Racial/ethnic differences in atrial fibrillation symptoms, treatment patterns, and outcomes: Insights from Outcomes Registry for Better Informed Treatment for Atrial Fibrillation Registry.
Academic Article Non-major bleeding with apixaban versus warfarin in patients with atrial fibrillation.
Academic Article Atrial fibrillation in women: treatment.
Academic Article Family history of atrial fibrillation is associated with earlier-onset and more symptomatic atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article Atrial Fibrillation and Fall Risk: What Are the Treatment Implications?
Academic Article Triple vs Dual Antithrombotic Therapy in Patients with Atrial Fibrillation and Coronary Artery Disease.
Academic Article Stability of International Normalized Ratios in Patients Taking Long-term Warfarin Therapy.
Academic Article Increased Heart Rate Is Associated With Higher Mortality in Patients With Atrial Fibrillation (AF): Results From the Outcomes Registry for Better Informed Treatment of AF (ORBIT-AF).
Academic Article Clinical outcomes in patients with atrial fibrillation according to sex during anticoagulation with apixaban or warfarin: a secondary analysis of a randomized controlled trial.
Academic Article Paroxysmal atrial fibrillation and the hazards of under-treatment.
Academic Article Heart Rhythm Monitoring Strategies for Cryptogenic Stroke: 2015 Diagnostics and Monitoring Stroke Focus Group Report.
Academic Article Antithrombotic drug use: scientific breakthroughs, biological limits and physician behaviour.
Academic Article Influence of statin therapy at time of stroke onset on functional outcome among patients with atrial fibrillation.
Academic Article Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 1.
Academic Article Choosing a particular oral anticoagulant and dose for stroke prevention in individual patients with non-valvular atrial fibrillation: part 2.
Academic Article Reversal Agents for Oral Antiplatelet and Anticoagulant Treatment During Bleeding Events: Current Strategies.
Grant Phase II Study - Development and Implementation of Clinical Practice Guidelines in a Large Teaching Hospital for the Use of Fragmin as Bridging Therapy
Academic Article Factors associated with non-vitamin K antagonist oral anticoagulants for stroke prevention in patients with new-onset atrial fibrillation: Results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Academic Article Efficacy and Safety of Apixaban Versus Warfarin in Patients with Atrial Fibrillation and a History of Cancer: Insights from the ARISTOTLE Trial.
Academic Article Oral anticoagulation management in patients with atrial fibrillation undergoing cardiac implantable electronic device implantation.
Academic Article 2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation.
Academic Article 2017?HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: Executive summary.
Academic Article Treatment of Atrial Fibrillation and Concordance With the American Heart Association/American College of Cardiology/Heart Rhythm Society Guidelines: Findings From ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation).
Academic Article Evidence Gaps in the Era of Non-Vitamin K Oral Anticoagulants.
Academic Article Mineralocorticoid Receptor Antagonism in Patients With Atrial Fibrillation: Findings From the ORBIT-AF (Outcomes Registry for Better Informed Treatment of Atrial Fibrillation) Registry.
Academic Article Prognostic Significance of Nuisance Bleeding in Anticoagulated Patients With Atrial Fibrillation.
Academic Article Use of Biomarkers to Predict Specific Causes of Death in Patients With Atrial Fibrillation.
Academic Article Characteristics and outcomes of adults with chronic obstructive pulmonary disease and atrial fibrillation.
Academic Article Therapeutic Strategies Following Major, Clinically Relevant Nonmajor, and Nuisance Bleeding in Atrial Fibrillation: Findings From ORBIT-AF.
Academic Article Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry.
Academic Article Asymmetric and Symmetric Dimethylarginine Predict Outcomes in Patients With Atrial Fibrillation: An ARISTOTLE Substudy.
Academic Article Effect of apixaban compared with warfarin on coagulation markers in atrial fibrillation.
Academic Article Stroke Risk and Treatment in Patients with Atrial Fibrillation and Low CHA2DS2-VASc Scores: Findings From the ORBIT-AF I and II Registries.
Academic Article Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT-AF.
Academic Article Treatment Persistence in Atrial Fibrillation: The Next Major Hurdle.
Academic Article Interacting medication use and the treatment effects of apixaban versus warfarin: results from the ARISTOTLE Trial.
Academic Article Thrombotic and hemorrhagic burden in women: Gender-related issues in the response to antithrombotic therapies.
Academic Article Association of frailty and cognitive impairment with benefits of oral anticoagulation in patients with atrial fibrillation.
Academic Article International normalized ratio control and subsequent clinical outcomes in patients with atrial fibrillation using warfarin.
Academic Article Comparison of Patient-Reported Care Satisfaction, Quality of Warfarin Therapy, and Outcomes of Atrial Fibrillation: Findings From the ORBIT - AF Registry.
Academic Article Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation.
Academic Article Dabigatran Reversal With Idarucizumab in Patients With Renal Impairment.
Academic Article Outcomes and Anticoagulation Use After Catheter Ablation for Atrial Fibrillation.
Grant Effectiveness and Safety of Antithrombotic Strategies after Joint Replacement
Academic Article Factors Associated With Large Improvements in Health-Related Quality of Life in Patients With Atrial Fibrillation: Results From ORBIT-AF.
Academic Article Discontinuation rates of warfarin versus direct acting oral anticoagulants in US clinical practice: Results from Outcomes Registry for Better Informed Treatment of Atrial Fibrillation II (ORBIT-AF II).
Academic Article Effect of Temporary Interruption of Warfarin Due to an Intervention on Downstream Time in Therapeutic Range in Patients With Atrial Fibrillation (from ORBIT AF).
Academic Article Evaluation of the Age, Biomarkers, and Clinical History-Bleeding Risk Score in Patients With Atrial Fibrillation With Combined Aspirin and Anticoagulation Therapy Enrolled in the ARISTOTLE and RE-LY Trials.

Highlights
Search Criteria
  • Antithrombotic
  • Therapy